Edition:
United States

GlaxoSmithKline Consumer Healthcare Ltd (GLSM.NS)

GLSM.NS on National Stock Exchange of India

6,170.05INR
6:10am EDT
Change (% chg)

Rs-14.80 (-0.24%)
Prev Close
Rs6,184.85
Open
Rs6,214.50
Day's High
Rs6,214.50
Day's Low
Rs6,132.60
Volume
6,820
Avg. Vol
20,208
52-wk High
Rs6,940.25
52-wk Low
Rs4,851.00

Select another date:

Tue, Mar 27 2018

Photo

GSK buys out Novartis in $13 billion consumer healthcare shake-up

FRANKFURT/ZURICH GlaxoSmithKline is buying Novartis out of their consumer healthcare joint venture for $13 billion, taking full control of products including Sensodyne toothpaste, Panadol headache tablets, muscle gel Voltaren, and Nicotinell patches. | Video

UPDATE 4-GSK buys out Novartis in $13 bln consumer healthcare shake-up

* Deal unravels JV agreed in 2014 (Adds fund manager quote, background on new Novartis CEO)

BRIEF-India's GlaxoSmithKline Consumer Healthcare Dec Qtr Profit Up 20 Pct

* DEC QUARTER PROFIT 1.64 BILLION RUPEES VERSUS PROFIT OF 1.36 BILLION RUPEES LAST YEAR

BRIEF-Neurometrix, Glaxosmithkline Announce Collaboration To Develop Quell Wearable Pain Relief Technology

* NEUROMETRIX AND GLAXOSMITHKLINE CONSUMER HEALTHCARE ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP AND EXPAND ACCESS TO QUELL WEARABLE PAIN RELIEF TECHNOLOGY

Select another date: